Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk

Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K antago...

Descripción completa

Detalles Bibliográficos
Autores principales: Haas, Sylvia, Bode, Christoph, Norrving, Bo, Turpie, Alexander GG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956810/
https://www.ncbi.nlm.nih.gov/pubmed/24648742
http://dx.doi.org/10.2147/VHRM.S55246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956810/
https://www.ncbi.nlm.nih.gov/pubmed/24648742
http://dx.doi.org/10.2147/VHRM.S55246

Ejemplares similares